URL has been copied successfully!
Shares of Enveric BioSciences (NASDAQ:ENVB) added over 92% in the premarket trading session on Monday. AtaiBeckley Inc (NASDAQ:ATAI) surged by 28.1%, while Compass Pathways (NASDAQ:CMPS) and Definium Therapeutics (NASDAQ:DFTX) saw their shares ascend by 26.1% and 14.6%, respectively, after President Donald Trump issued an executive order on Saturday instructing health regulators to hasten the review process of psychedelic drugs.
Other companies in the sector also reaped benefits. GH Research (NASDAQ:GHRS) shares rose by 17.23%.
…
Please follow us:
This post was originally published here
